Surging subscriber growth and profitability prompt ambitious long-term targets for 2030 Hims & Hers Health, Inc. (HIMS), a leading digital...
Partnership with Hims & Hers, Ro, and LifeMD aims to capture patients as compounded versions disappear Novo Nordisk (NVO) is...
Wall Street Reacts to Leadership Uncertainty in Biopharma Approvals The resignation of Peter Marks, director of the FDA’s Center for...
Illumina Takes a Hit as Beijing Retaliates Against U.S. Tariffs China announced on Tuesday a ban on imports of genetic...
Phase 1 Trial of HCW9302 Marks a Milestone in Autoimmune Disease Research HCW Biologics (HCWB), a clinical-stage biopharmaceutical company specializing...
Slow RSV shot adoption and waning COVID-19 vaccine sales weigh on revenue projections Moderna (MRNA) announced a $1 billion reduction...
Disappointing Data Spurs $125 Billion Market Value Drop Novo Nordisk’s (NVO) ambitions in the competitive obesity drug market took a...
Health insurer clarifies position amid investor interest following Trump’s re-election and merger hopes Cigna Group (CI) has officially stated it...
Clinical Data from Oral and Subcutaneous Doses Show Effective Weight Loss and Support Potential for Long-Term Dosing Strategies Viking Therapeutics...
Strong Growth in Keytruda Revenue Contrasts with Decline in Gardasil Sales in China Amid Economic and Regulatory Challenges Merck &...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?